Venus Medtech (Hangzhou) Inc. (HKG:2500)

Venus Medtech (Hangzhou) Statistics

Total Valuation

HKG:2500 has a market cap or net worth of HKD 1.32 billion. The enterprise value is 1.54 billion.

Market Cap	1.32B
Enterprise Value	1.54B

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2500 has 437.90 million shares outstanding.

Current Share Class	437.90M
Shares Outstanding	437.90M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.66%
Owned by Institutions (%)	15.59%
Float	289.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.82
PB Ratio	0.58
P/TBV Ratio	1.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.18
EV / Sales	3.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.22

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.24.

Current Ratio	1.82
Quick Ratio	1.07
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	-2.89
Interest Coverage	-21.18

Financial Efficiency

Return on equity (ROE) is -26.87% and return on invested capital (ROIC) is -6.42%.

Return on Equity (ROE)	-26.87%
Return on Assets (ROA)	-5.29%
Return on Invested Capital (ROIC)	-6.42%
Return on Capital Employed (ROCE)	-10.93%
Revenue Per Employee	773,838
Profits Per Employee	-1.16M
Employee Count	691
Asset Turnover	0.12
Inventory Turnover	0.91

Taxes

Income Tax	-24.52M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.01
52-Week Price Change	n/a
50-Day Moving Average	2.53
200-Day Moving Average	2.89
Relative Strength Index (RSI)	56.05
Average Volume (20 Days)	2,808,537

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2500 had revenue of HKD 468.17 million and -704.14 million in losses. Loss per share was -1.61.

Revenue	468.17M
Gross Profit	355.00M
Operating Income	-325.27M
Pretax Income	-729.46M
Net Income	-704.14M
EBITDA	-303.91M
EBIT	-325.27M
Loss Per Share	-1.61

Balance Sheet

The company has 321.40 million in cash and 540.87 million in debt, with a net cash position of -219.47 million or -0.50 per share.

Cash & Cash Equivalents	321.40M
Total Debt	540.87M
Net Cash	-219.47M
Net Cash Per Share	-0.50
Equity (Book Value)	2.26B
Book Value Per Share	5.17
Working Capital	360.84M

Cash Flow

In the last 12 months, operating cash flow was -187.29 million and capital expenditures 300,244, giving a free cash flow of -186.99 million.

Operating Cash Flow	-187.29M
Capital Expenditures	300,244
Free Cash Flow	-186.99M
FCF Per Share	-0.43

Margins

Gross margin is 75.83%, with operating and profit margins of -69.48% and -150.40%.

Gross Margin	75.83%
Operating Margin	-69.48%
Pretax Margin	-155.81%
Profit Margin	-150.40%
EBITDA Margin	-64.91%
EBIT Margin	-69.48%
FCF Margin	n/a

Dividends & Yields

HKG:2500 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-53.42%
FCF Yield	-14.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2500 has an Altman Z-Score of -1.15 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.15
Piotroski F-Score	2